Shilpa Medicare Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 5 Aug 2026

Company page: Shilpa Medicare share price, financials & guidance record

Shilpa Medicare delivered its strongest quarterly performance in Q1 FY27, with record revenue and EBITDA driven by growth across all segments. The company showcased significant improvements in ROCE and received a credit rating upgrade, underscoring its successful strategic transformation. Management expressed confidence in its extensive product pipeline, anticipating several key launches and commercializations in FY27 and FY28, while also addressing the impact of tax regime changes and raw material costs on profitability.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 105.4%, net profit up 209.5% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	130	125	126	92	135 +4%	166 +33%	201 +60%	189 +105%
Expenses	87	103	88	75	96	135	141	133
EBITDA	43	22	38	17	39 −9%	31 +41%	60 +58%	56 +229%
Margin	33%	18%	30%	18%	29%	19%	30%	30%
Other income	20	16	-34	13	15	9	35	13
Interest	1	1	2	2	2	3	3	3
Depreciation	12	12	12	13	13	14	14	15
Profit before tax	50	25	-10	15	39 −22%	24 −4%	78 +880%	51 +240%
Tax rate	40%	37%	-43%	-40%	21%	33%	9%	-27%
Net profit	30	16	-6	21	31 +3%	16 +0%	71 +1283%	65 +210%
EPS	1.53	0.80	-0.29	1.06	1.58	0.81	3.63	3.32

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls